John P Sharp - Net Worth and Insider Trading
John P Sharp Net Worth
The estimated net worth of John P Sharp is at least $2 Million dollars as of 2025-04-29. John P Sharp is the VP Finance and CFO of Ligand Pharmaceuticals Inc and owns about 17,667 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $2 Million. John P Sharp is also the CFO and Secretary of PhaseBio Pharmaceuticals Inc and owns about 5,000 shares of PhaseBio Pharmaceuticals Inc (PHASQ) stock worth over $1. Details can be seen in John P Sharp's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John P Sharp has not made any transactions after 2018-12-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John P Sharp
John P Sharp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John P Sharp owns 3 companies in total, including PhaseBio Pharmaceuticals Inc (PHASQ) , Ligand Pharmaceuticals Inc (LGND) , and Sequenom Inc (SQNM) .
Click here to see the complete history of John P Sharp’s form 4 insider trades.
Insider Ownership Summary of John P Sharp
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| PHASQ | PhaseBio Pharmaceuticals Inc | 2020-02-12 | Chief Financial Officer |
| LGND | Ligand Pharmaceuticals Inc | 2014-02-12 | VP Finance and CFO |
| SQNM | Sequenom Inc | 2007-01-18 | Treasurer |
John P Sharp Latest Holdings Summary
John P Sharp currently owns a total of 2 stocks. Among these stocks, John P Sharp owns 17,667 shares of Ligand Pharmaceuticals Inc (LGND) as of February 12, 2014, with a value of $2 Million and a weighting of 100%. John P Sharp also owns 5,000 shares of PhaseBio Pharmaceuticals Inc (PHASQ) as of December 7, 2018, with a value of $1 and a weighting of 0%.
Latest Holdings of John P Sharp
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2014-02-12 | 17,667 | 108.88 | 1,923,583 |
| PHASQ | PhaseBio Pharmaceuticals Inc | 2018-12-07 | 5,000 | 0.00 | 1 |
Holding Weightings of John P Sharp
John P Sharp Form 4 Trading Tracker
According to the SEC Form 4 filings, John P Sharp has made a total of 0 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 86,953 shares on February 12, 2014, which brought John P Sharp around $6 Million.
According to the SEC Form 4 filings, John P Sharp has made a total of 0 transactions in PhaseBio Pharmaceuticals Inc (PHASQ) over the past 5 years. The most-recent trade in PhaseBio Pharmaceuticals Inc is the acquisition of 5,000 shares on December 7, 2018, which cost John P Sharp around $19,200.
Insider Trading History of John P Sharp
- 1
John P Sharp Trading Performance
GuruFocus tracks the stock performance after each of John P Sharp's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John P Sharp is -26.65%. GuruFocus also compares John P Sharp's trading performance to market benchmark return within the same time period. The performance of stocks bought by John P Sharp within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John P Sharp's insider trading performs compared to the benchmark.
Performance of John P Sharp
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -14.18 | | | | | |
| Relative Return to S&P 500(%) | -11.01 | | | | | |
John P Sharp Ownership Network
Ownership Network List of John P Sharp
Ownership Network Relation of John P Sharp
John P Sharp Owned Company Details
What does PhaseBio Pharmaceuticals Inc do?
Who are the key executives at PhaseBio Pharmaceuticals Inc?
John P Sharp is the Chief Financial Officer of PhaseBio Pharmaceuticals Inc. Other key executives at PhaseBio Pharmaceuticals Inc include 10 percent owner New Enterprise Associates 13 Lp , VP & Human Resources Glen Burkhardt , and Chief Commercial Officer Jonathan Birchall .
PhaseBio Pharmaceuticals Inc (PHASQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of PhaseBio Pharmaceuticals Inc (PHASQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PhaseBio Pharmaceuticals Inc (PHASQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
PhaseBio Pharmaceuticals Inc (PHASQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
PhaseBio Pharmaceuticals Inc Insider Transactions
John P Sharp Mailing Address
Above is the net worth, insider trading, and ownership report for John P Sharp. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, John P Sharp's mailing address is: La Jolla Ca 92037.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
